- Home » News and EventsPage 33
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Invest $5 million to Create Drug Development Center of Excellence
Apr 24, 2018
SOMERSET, N.J. – April 24, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, …
Catalent to Lead Multiple Workshops at Upcoming US GCSG Conference
Apr 19, 2018
Catalent to Lead Multiple Workshops at Upcoming US GCSG Conference. SOMERSET, N.J. – April 19, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and devel…
Catalent Completes $5.5 Million Expansion at Philadelphia Facility
Apr 12, 2018
SOMERSET, N.J. – April 12, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, …
Catalent to Present at Upcoming INTERPHEX Convention
Apr 11, 2018
SOMERSET, N.J. – April 10, 2018 — Catalent Pharma Solutions (Booth 1245), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer heal…
Catalent To Discuss Potential Implications of Brexit on Clinical Supply
Mar 8, 2018
Catalent To Discuss Potential Implications of Brexit on Clinical Supply. SOMERSET, N.J. – March 8, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and d…
Catalent Institute to Host Discussion on Patient-Focused Drug Design
Mar 1, 2018
The Catalent Applied Drug Delivery Institute today announced that it is to hold a one-day symposium titled “Smart Drug Development & Design from Candidate to Phase I” on Thursday, March 8, at Novartis…
Catalent Completes $4.6 Million Expansion at Singapore Facility
Feb 28, 2018
SOMERSET, N.J. & PHAR-EAST, Singapore – February 28, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and …
Catalent to Present at Clinical Trial Supply New England
Feb 22, 2018
Catalent to Present at Clinical Trial Supply New England. SOMERSET, N.J. – February 22, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development …
Biohaven Announces Exclusive License with Catalent for Zydis® ODT
Feb 21, 2018
(NYSE: CTLT) (“Catalent”) to provide Catalent’s Zydis® ODT (orally disintegrating tablet) fast-dissolving formulation for the development of Biohaven’s lead calcitonin-gene related peptide (CGRP) anta…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.